FATE - Fate Therapeutics appoints new CFO to support autoimmune program expansion October, 14 2025 08:15 AM Fate Therapeutics Inc. 2025-10-14 08:15:40 ET More on Fate Therapeutics Fate Therapeutics: Recent Update Met With Selling, But Positives Exist Seeking Alpha’s Quant Rating on Fate Therapeutics Historical earnings data for Fate Therapeutics Financial information for Fate Therapeutics For further details see: Fate Therapeutics appoints new CFO to support autoimmune program expansion